ESHG: Monday, June 25

Monday, June 25, 2012
08.30 - 10.00	Concurrent Symposia S09 - S12
	S09. Cancer genetics S09.1 Cancer immunoediting, Michele Teng, Australia S09.2 Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem-Cell States in the Breast , Christina Scheel, Munich, Germany S09.3 Microsatelite instability andcancers: From biology to clinics, Alex Duval, France S10. De novo mutations: A common cause of common disease? S10.1 Estimation of the human mutation rate by whole-genome sequencing, Lynn Jorde, United States S10.2 Fragile genomes generate more de novo mutations, Evan Eichler, United States S10.3 De Novo Mutations in Neurodevelopmental disorders , Simon Girard, Canada S11. Primary microcephaly S11.1 Genetic basis of primary microcephaly, C Geoffrey Woods, United Kingdom S11.2 Clinical aspects of primary microcephaly, Alain Verloes, France S11.3 DNA repair and microcephaly, Bernd Wollnik, Germany S12. Molecular basis of Lymphedema S12.1 Molecular classification of primary lymphedema, Pia Ostergaard, United Kingdom S12.2 Mouse models of lymphedema, Tatyana Petrova, Switzerland S12.3 Therapeutic trials in lymphedema, Anne Saaristo, Finland
08.30 - 10.00	Educational Session 6
	ES6. Neuromuscular diseases ES6.1 ALS, Mario Sabatelli, Italy ES6.1 Hereditery neuropathies, Vincent Timmermann, Belgium

10.00 - 10.30	Coffee Break, Free Poster Viewing, Exhibition

10.30 - 11.30	Poster Viewing with Authors (Even poster numbers)

11.30 - 13.15	Free Poster Viewing, Exhibition, Lunch

11.40 - 13.10	Educational Session 7
	ES7. Next generation sequencing goes diagnostics: First experiences ES7.1 CLINseq, Leslie Biesecker, United States ES7.2 BRCA1 and 2 diagnostics, Gert Matthijs, Belgium
11.40 - 13.10	Corporate Satellites
	Abbott Molecular Agilent Technologies

13.15 - 14.45	Concurrent Sessions C07 - C12
	C07. NGS Going Clinic C08. Functional Genomics C09. Clinical Genetics of Bone and Connective Tissue Disorders C10. Clinical Aspects in Cancer Genetics C11. Neurological and Sensory Diseases: From Gene to Function C12. Metabolic Diseases: From Gene to Function See session details

14.45 - 15.15	Fitness Break, Free Poster Viewing, Exhibition

15.15 - 16.45	Workshops W11 - W16
	Workshop 11: Dysmorphology 2 (Dian Donnai & Jill Clayton-Smith) Workshop 12: Predictivity, Genetic Testing and Insurance (Pascal Borry) Workshop 13: Dilemmas in HD practice (joint with EMPAG) (Rhona Macleod, D. Craufurd) Workshop 14: Progress in understanding of our genome through sharing of data - Debate (Joris Veltman) Workshop 15: USCS Genome Browser II (Robert Kuhn) See Workshop programme details
15.15 - 16.45	Corporate Satellites
	Life Technologies Roche-NimbleGen

16.45 - 17.15	Coffee Break

17.15 - 18.45	Concurrent Symposia S13 - S16
	S13. Intellectual disability: genes, proteins and model organisms S13.1 Exome sequencing in sporadic autism spectrum disorders, Jay Shendure, United States S13.2 Autism genetics: at the crossroads of genomics and cognitive neuroscience, Daniel H. Geschwind, United States S13.3 Large-scale dissection of molecular networks and mechanisms underlying Intellectual Disability Disorders, Annette Schenck, The Netherlands S14. From DNA sequence to genome function S14.1 Identification of cis- and trans-regulatory variation modulating microRNA expression levels, Stylianos Antonarakis, Switzerlands S14.2 Long noncoding RNAs with enhancer-like function in human cells, Roderic Guigo, Spain S14.3 Transcribed dark matter: meaning or myth?, Chris Ponting, United Kingdom S15. Bone diseases and therapeutic perspectives S15.1 LRP5 in bone, Matthew L. Warman, United States S15.2 Acromelic dysplasia and TGFbeta signaling, V. Cormier-Daire, France S15.3 Osteogenesis imperfecta, Brendan Lee, United States S16. Debate on Informed Consent in New Technologies (joint with EMPAG) S16.1 How to inform individuals of the relevance of incidental WGA findings?, Christian Netzer, Germany S16.2 Biobanks: should individuals be informed of findings from biobank studies? Can informed consent be realized?, Anne Cambon-Thomsen, France S16.3 Informed consent in non-invasive prenatal diagnosis, Zuzana Deans, United Kingdom
17.15 - 18.45	Educational Session 8
	ES8. Trinucleotid repeat disorders ES8.1 Huntington, Alexandra Durr, France ES8.2 Myotonic dystrophy, Darren Monckton, United Kingdom
20.00	ESHG Congress Party

To top

Monday, June 25

Monday, June 25, 2012

08.30 - 10.00

Concurrent Symposia S09 - S12

S09. Cancer genetics

S10. De novo mutations: A common cause of common disease?

S11. Primary microcephaly

S12. Molecular basis of Lymphedema

08.30 - 10.00

Educational Session 6

ES6. Neuromuscular diseases

10.30 - 11.30

Poster Viewing with Authors (Even poster numbers)

11.40 - 13.10

Educational Session 7

ES7. Next generation sequencing goes diagnostics: First experiences

11.40 - 13.10

Corporate Satellites

Abbott Molecular

Agilent Technologies

13.15 - 14.45

Concurrent Sessions C07 - C12

C07. NGS Going Clinic

C08. Functional Genomics

C09. Clinical Genetics of Bone and Connective Tissue Disorders

C10. Clinical Aspects in Cancer Genetics

C11. Neurological and Sensory Diseases: From Gene to Function

C12. Metabolic Diseases: From Gene to Function

15.15 - 16.45

Workshops W11 - W16

15.15 - 16.45

Corporate Satellites

Life Technologies

Roche-NimbleGen

17.15 - 18.45

Concurrent Symposia S13 - S16

S13. Intellectual disability: genes, proteins and model organisms

S14. From DNA sequence to genome function

S15. Bone diseases and therapeutic perspectives

S16. Debate on Informed Consent in New Technologies (joint with EMPAG)

17.15 - 18.45

Educational Session 8

ES8. Trinucleotid repeat disorders

20.00

ESHG Congress Party

ESHG 2012